Irreversible electroporation of renal cell carcinoma: A first-in-man phase i clinical study

CardioVascular and Interventional Radiology

Volumn 34, Issue 1, 2011, Pages 132-138

  Pech, MacIej ^a   Janitzky, Andreas ^a   Wendler, Johann Jacob ^a   Strang, Christof ^a   Blaschke, Simon ^a   Dudeck, Oliver ^a   Ricke, Jens ^a   Liehr, Uwe Bernd ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Ablation; Interventional radiology; Irreversible electroporation; Renal carcinoma

Indexed keywords

ABLATION THERAPY; ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CLINICAL ARTICLE; ELECTROCARDIOGRAPHY; ELECTROGRAPHY; FEASIBILITY STUDY; FEMALE; FIRST IN HUMAN STUDY; HEART FUNCTION; HEMATOLOGICAL PARAMETERS; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRREVERSIBLE ELECTROPORATION; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; ST SEGMENT; SUPRAVENTRICULAR PREMATURE BEAT;

ADULT; AGED; CARCINOMA, RENAL CELL; ELECTROCARDIOGRAPHY; ELECTROPORATION; FEASIBILITY STUDIES; FEMALE; HEMODYNAMICS; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79251599418     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-9964-1     Document Type: Article

References (27)

1. Bertacchini C, Margotti PM, Bergamini E, Lodi A, Ronchetti M, Cadossi R (2007) Design of an irreversible electroporation system for clinical use. Technol Cancer Res Treat 6(4):313-320
2. Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality-clinical implications. Technol Cancer Res Treat 6(1):37-48
3. Rubinsky B (2007) Irreversible electroporation in medicine. Technol Cancer Res Treat 6(4):255-260
4. Hines-Peralta A, Goldberg SN (2004) Review of radiofrequency ablation for renal cell carcinoma. Clin Cancer Res 10(18 Pt 2):6328S-6334S
5. Yoon SK, Choi JC, Cho JH, Oh JY, Nam KJ et al.(2009) Radiofrequency ablation of renal VX2 tumors with and without renal artery occlusion in a rabbit model: feasibility, therapeutic efficacy, and safety. Cardiovasc Intervent Radiol 32(6):1241-1246
6. Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PF, Patard JJ et al.(2007) Renal cell carcinoma guideline. Eur Urol 51(6):1502-1510
7. Al Sakere B, André F, Bernat C, Connault E, Opolon P, Davalos RV et al.(2007) Tumor ablation with irreversible electroporation. PLoS One 2(11):e1135
8. Garcia PA, Rossmeisl JH, Robertson J, Ellis TL, Davalos RV (2009) Pilot study of irreversible electroporation for intracranial surgery. Conf Proc IEEE Eng Med Biol Soc 1:6513-6516
9. Y Granot A Ivorra E Maor B Rubinsky 2009 In vivo imaging of irreversible electroporation by means of electrical impedance tomography Phys Med Biol 54 16 4927 4943 10.1088/0031-9155/54/16/006 19641242
10. G Onik P Mikus B Rubinsky 2007 Irreversible electroporation: implications for prostate ablation Technol Cancer Res Treat 6 4 295 300 17668936
11. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H (2005) Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 173(6):1889-1892
12. KS Hafez AF Fergany AC Novick 1999 Nephron-sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging J Urol 162 6 1930 1933 1:STN:280:DC%2BD3c%2FjsVyhug%3D%3D 10.1016/S0022-5347(05)68071-8 10569540
13. Bell ET (1950) Renal diseases. Lippincott, Philadelphia, PA, pp 428-439
14. Peterson RO (1986) Urologic pathology. Lippincott, Philadelphia, PA, pp 85-110
15. MA Bosniak 1995 Observation of small incidentally detected renal masses Semin Urol Oncol 13 4 267 272 1:STN:280:DyaK287mslWntA%3D%3D 8595550
16. Nissenkorn, Bernhelm J (1995) Multicentricity in renal cell carcinoma. J Urol 153(3 Pt 1):620-622
17. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175(2):425-431
18. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ (2003) Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 180(6):1503-1508
19. Matlaga BR, Zagoria RJ, Woodruff RD, Torti FM, Hall MC (2002) Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J Urol 168(6):2401-2405
20. DA Gervais FJ McGovern RS Arellano 2003 Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors Radiology 226 2 417 424 10.1148/radiol.2262012062 12563135
21. Pavlovich C, Walther M, Choyke P, Pautler SE, Chang R, Linehan WM et al.(2002) Percutaneous radiofrequency ablation of small renal tumors: initial results. J Urol 167(1):10-15
22. Tacke J, Mahnken A, Bucker A, Rohde D, Günther RW (2001) Nephron-sparing percutaneous ablation of a 5 cm renal cell carcinoma by superselective embolization and percutaneous RF-ablation. Rofo 173(11):980-983
23. Gebauer B, Werk M, Lopez-Hanninen E, Felix R, Althaus P (2007) Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy. Cardiovasc Intervent Radiol 30(4):644-649
24. RE Dib NJ Touma A Kapoor 2009 Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses Can Urol Assoc J 3 2 143 149 19424470
25. EW Lee CT Loh ST Kee 2007 Imaging-guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation Technol Cancer Res Treat 6 4 287 294 17668935
26. Maor E, Ivorra A, Leor J, Rubinsky B (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6(4):307-312
27. L Miller J Leor B Rubinsky 2005 Cancer cells ablation with irreversible electroporation Technol Cancer Res Treat 4 6 699 705 16292891